论文信息 - Combination of palbociclib with navitoclax based-therapies enhances in vivo antitumoral activity in triple-negative breast cancer. - 字舞流文

Combination of palbociclib with navitoclax based-therapies enhances in vivo antitumoral activity in triple-negative breast cancer.

M. Orzáez | Juan F. Blandez | A. Lérida-Viso | A. García-Fernández | I. Galiana | J. Blandez | Alejandra Estepa-Fernández | Félix Sancenon-Galarza | R. Martínez-Máñez | R. Martínez‐Máñez | A. García‐Fernández | Irene Galiana